ASCO & The Conquer Cancer Foundation announce merit awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Conquer Cancer Foundation of the American Society of Clinical Oncology announced the recipients of its 2019 ASCO Annual Meeting Merit Awards. These awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO annual meeting.

This year, Conquer Cancer recognized 125 recipients with Merit Awards at the 2019 ASCO Annual Meeting, having already awarded 33 symposia-specific Merit Awards in 2019. These oncology professionals are recognized for their respective field and research advancements within the cancer care community.

The complete list of 2019 ASCO Annual Meeting Merit Award is posted here.

Special Merit Awards are presented each year to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. The ASCO Scientific Program Committee will present five additional recipients with Special Merit Awards in their respective abstract categories:

  • Dai Chihara, NCI at NIH

    • Receives the Bradley Stuart Beller Endowed Merit Award for the highest ranking abstract overall.

    • Supported by Friends and Family of Dr. and Mrs. Ronald Beller.

  • Sarah Abou Alaiwi, Dana-Farber Cancer Institute

    • Receives the Allen S. Lichter, MD, Endowed Merit Award for the second highest ranking abstract overall.

  • Po-Ju Lin, University of Rochester Medical Center

    • Receives the Pain and Symptom Management Special Merit Award for the highest ranked abstract in pain and symptom management research.

  • Adriana Fonseca, The Hospital for Sick Children

    • Receives the Brigid Leventhal Special Merit Award for the top-ranking abstract in pediatric oncology.

    • Supported by The Berry Family.

  • Sumit Gupta, The Hospital for Sick Children

    • Receives the James B. Nachman Endowed ASCO Junior Faculty Award in Pediatric Oncology for the highest scoring abstract in pediatric oncology.

    • Supported by Friends and Family of Dr. James B. Nachman.

Table of Contents

YOU MAY BE INTERESTED IN

Artificial intelligence is starting to transform life sciences by accelerating drug discovery and development, optimizing clinical trials, and creating personalized treatments for cancer patients, speakers said at the Sept. 18 unveiling of the American Association for Cancer Research 2024 Cancer Progress Report. 

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login